Pacer Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,940
| Closed | -$1.65M | – | 3506 |
|
|
2025
Q1 | $1.65M | Sell |
14,940
-16,897
| -53% | -$1.87M | ﹤0.01% | 1011 |
|
|
2024
Q4 | $4.35M | Buy |
31,837
+3,044
| +11% | +$416K | 0.01% | 651 |
|
|
2024
Q3 | $3.32M | Sell |
28,793
-3,097
| -10% | -$357K | 0.01% | 759 |
|
|
2024
Q2 | $4.39M | Buy |
31,890
+13,782
| +76% | +$1.9M | 0.01% | 610 |
|
|
2024
Q1 | $2.5M | Buy |
18,108
+3,500
| +24% | +$483K | 0.01% | 772 |
|
|
2023
Q4 | $1.92M | Buy |
14,608
+6,450
| +79% | +$850K | 0.01% | 799 |
|
|
2023
Q3 | $918K | Sell |
8,158
-12,344
| -60% | -$1.39M | ﹤0.01% | 899 |
|
|
2023
Q2 | $1.93M | Buy |
+20,502
| New | +$1.93M | 0.01% | 746 |
|
|
2023
Q1 | – | Sell |
-18,422
| Closed | -$2.2M | – | 2314 |
|
|
2022
Q4 | $2.2M | Buy |
18,422
+14,218
| +338% | +$1.7M | 0.01% | 551 |
|
|
2022
Q3 | $447K | Buy |
+4,204
| New | +$447K | ﹤0.01% | 859 |
|
|
2022
Q1 | – | Sell |
-12,247
| Closed | -$1.04M | – | 2457 |
|
|
2021
Q4 | $1.04M | Buy |
12,247
+2,581
| +27% | +$220K | 0.01% | 1173 |
|
|
2021
Q3 | $927K | Sell |
9,666
-234
| -2% | -$22.4K | 0.01% | 900 |
|
|
2021
Q2 | $963K | Buy |
9,900
+9,101
| +1,139% | +$885K | 0.01% | 868 |
|
|
2021
Q1 | $78K | Sell |
799
-656
| -45% | -$64K | ﹤0.01% | 1327 |
|
|
2020
Q4 | $139K | Buy |
1,455
+542
| +59% | +$51.8K | ﹤0.01% | 1299 |
|
|
2020
Q3 | $88K | Buy |
+913
| New | +$88K | ﹤0.01% | 1269 |
|
|
2018
Q4 | – | Sell |
-2,661
| Closed | -$327K | – | 867 |
|
|
2018
Q3 | $327K | Buy |
+2,661
| New | +$327K | 0.01% | 939 |
|
|
2018
Q1 | – | Sell |
-1,925
| Closed | -$149K | – | 1096 |
|
|
2017
Q4 | $149K | Sell |
1,925
-8,707
| -82% | -$674K | 0.01% | 925 |
|
|
2017
Q3 | $652K | Sell |
10,632
-345
| -3% | -$21.2K | 0.06% | 519 |
|
|
2017
Q2 | $505K | Buy |
10,977
+1,167
| +12% | +$53.7K | 0.05% | 599 |
|
|
2017
Q1 | $425K | Buy |
9,810
+1,780
| +22% | +$77.1K | 0.05% | 588 |
|
|
2016
Q4 | $311K | Buy |
8,030
+472
| +6% | +$18.3K | 0.04% | 667 |
|
|
2016
Q3 | $383K | Buy |
7,558
+1,302
| +21% | +$66K | 0.06% | 480 |
|
|
2016
Q2 | $284K | Buy |
+6,256
| New | +$284K | 0.04% | 599 |
|